- Home
- EXEL vs CHKP Comparison
EXEL vs CHKP Comparison
Compare EXEL & CHKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | CHKP |
|---|---|---|
| Founded | 1994 | 1993 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 14.1B |
| IPO Year | 2000 | 1997 |
Fundamental Metrics
Financial Performance| Metric | EXEL | CHKP |
|---|---|---|
| Price | $57.57 | $133.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 20 |
| Target Price | $46.50 | ★ $199.50 |
| AVG Volume (30 Days) | ★ 1.8M | 972.9K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.95 | N/A |
| EPS | ★ 1.60 | N/A |
| Revenue | ★ $452,477,000.00 | N/A |
| Revenue This Year | $13.61 | $8.31 |
| Revenue Next Year | $13.13 | $6.03 |
| P/E Ratio | $35.76 | ★ $17.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.76 | $112.23 |
| 52 Week High | $59.72 | $210.66 |
Technical Indicators
Market Signals| Indicator | EXEL | CHKP |
|---|---|---|
| Relative Strength Index (RSI) | 54.22 | 49.13 |
| Support Level | $54.38 | $127.58 |
| Resistance Level | $59.72 | $141.57 |
| Average True Range (ATR) | 1.50 | 4.31 |
| MACD | -0.06 | -0.30 |
| Stochastic Oscillator | 55.36 | 35.36 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About CHKP Check Point Software Technologies Ltd.
Check Point Software Technologies is a pure-play cybersecurity vendor. The company offers solutions for network, endpoint, cloud, and mobile security in addition to security management. Check Point, a software specialist, sells to enterprises, businesses, and consumers. Around 50% of revenue is generated in Europe, the Middle East, and Africa, 40% from the Americas, and 10% from the Asia-Pacific region. The firm, based in Tel Aviv, Israel, was founded in 1993 and has about 5,000 employees.